Haw Par Corporation Ltd
SGX:H02
Haw Par Corporation Ltd
SGX:H02
Price:
9.64 SGD
-2.13%
Market Closed
Updated:
May 4, 2024
Haw Par Corporation Ltd
Cash from Operating Activities
|
Haw Par Corporation Ltd
Cash from Operating Activities Peer Comparison
Comparables:
WVE
H
1J5
I
42C
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Haw Par Corporation Ltd
SGX:H02
|
Cash from Operating Activities
S$62.7m
|
CAGR 3-Years
36%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-4%
|
|
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Cash from Operating Activities
-$19.4m
|
CAGR 3-Years
45%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Cash from Operating Activities
S$5.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
I
|
IX Biopharma Ltd
SGX:42C
|
Cash from Operating Activities
-S$6.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
See Also
What is Haw Par Corporation Ltd's Cash from Operating Activities?
Cash from Operating Activities
62.7m
SGD
62.7m
SGD
Based on the financial report for Dec 31, 2023, Haw Par Corporation Ltd's Cash from Operating Activities amounts to 62.7m SGD.
What is Haw Par Corporation Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-4%
-4%
Over the last year, the Cash from Operating Activities growth was 53%. The average annual Cash from Operating Activities growth rates for Haw Par Corporation Ltd have been 36% over the past three years , -2% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet
